Literature DB >> 2104575

The role of human interleukin-6 in B-cell isotype regulation and differentiation.

J N Bertolini1, E M Benson.   

Abstract

Human Interleukin-6 (IL-6) is a cytokine secreted by T cells, as well as a variety of other cell types, which exhibits B-cell differentiating activity. The recent cloning of the gene that codes for this molecule has allowed us the opportunity to study the function of this molecule alone and in conjunction with other lymphokines in human B-cell isotype-regulation and differentiation. Recombinant human IL-6 enhances immunoglobulin (Ig) M and G secretion by B-cells activated by Staphylococcal A Cowan strain (SAC) and enhances IgM, IgG, and IgA secretion by B-cells activated by pokeweed mitogen. IL-6 also augments immunoglobulin secretion of differing isotypes from various Epstein-Barr Virus transformed B-cell lines. However, IL-6 does not alter the secreted isotype of naive surface IgM-positive B-cells. As human T-cells secrete other lymphokines in association with IL-6 after activation we examined the interaction of Interleukin-2 (IL-2) gamma-interferon (IFN-gamma) and Interleukin-4 (IL-4) with IL-6 on B-cell immunoglobulin secretion. IL-2 and IL-4 synergized with IL-6 in augmenting immunoglobulin secretion by SAC-activated B-cells. IFN-gamma significantly inhibited the Ig secretion of SAC-activated B-cells cocultured with IL-6 alone or in combination with IL-2. These results demonstrate that human recombinant IL-6 augments immunoglobulin secretion of isotype-committed B-cells but it does not induce a change in the isotype secreted. In addition, this lymphokine synergizes with IL-2 and IL-4 in supporting Ig secretion. However, IFN-gamma significantly inhibits IL-6 induced Ig secretion.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2104575     DOI: 10.1016/0008-8749(90)90074-2

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  13 in total

1.  Interleukin-6, but not interleukin-4, is expressed by Reed-Sternberg cells in Hodgkin's disease with or without histologic features of Castleman's disease.

Authors:  S M Hsu; S S Xie; P L Hsu; J A Waldron
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

2.  Regulation of human IgG subclass production by cytokines: human IgG subclass production enhanced differentially by interleukin-6.

Authors:  Y Kawano; T Noma; K Kou; I Yoshizawa; J Yata
Journal:  Immunology       Date:  1995-02       Impact factor: 7.397

3.  Increased IL-6 gene expression and production in patients with common variable immunodeficiency.

Authors:  F Pandolfi; R Paganelli; A Oliva; I Quinti; V Polidori; E Fanales-Belasio; E Guerra; F Aiuti
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

4.  Involvement of Stat3 in interleukin-6-induced IgM production in a human B-cell line.

Authors:  M Faris; N Kokot; N Stahl; A E Nel
Journal:  Immunology       Date:  1997-03       Impact factor: 7.397

5.  B-cell stimulatory cytokines and markers of immune activation are elevated several years prior to the diagnosis of systemic AIDS-associated non-Hodgkin B-cell lymphoma.

Authors:  Elizabeth Crabb Breen; Shehnaz K Hussain; Larry Magpantay; Lisa P Jacobson; Roger Detels; Charles S Rabkin; Richard A Kaslow; Daina Variakojis; Jay H Bream; Charles R Rinaldo; Richard F Ambinder; Otoniel Martinez-Maza
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-04-28       Impact factor: 4.254

6.  Localization of IFN-gamma and IL-6 mRNA in murine intestine by in situ hybridization.

Authors:  S Bao; S Goldstone; A J Husband
Journal:  Immunology       Date:  1993-12       Impact factor: 7.397

Review 7.  Interleukin-6 in autoimmune disease. Role of IL-6 in physiology and pathology of the immune defense.

Authors:  L Graeve; M Baumann; P C Heinrich
Journal:  Clin Investig       Date:  1993-08

8.  IL-2 enhances polyclonal IgM but not IgM-rheumatoid factor synthesis by activated human peripheral blood B cells.

Authors:  M Callaghan; A Whelan; C Feighery; B Bresnihan
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

9.  Functional heterogeneity and pathogenic significance of interleukin-6 in B-cell lymphomas.

Authors:  S M Hsu; S S Xie; J A Waldron
Journal:  Am J Pathol       Date:  1992-10       Impact factor: 4.307

10.  IgG4-Related Lymphadenopathy.

Authors:  Yasuharu Sato; Tadashi Yoshino
Journal:  Int J Rheumatol       Date:  2012-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.